Ronald D. Seidel III, Ph.D.

Ron Seidel is co-founder of Cue Biopharma and co-inventor of several of its core technologies. He currently serves as Senior Scientific Advisor to Cue Biopharma. From the Company’s formation in 2015 through June of 2021, Dr. Seidel had oversight of daily Company operations integrating R&D and intellectual property (IP) development strategy with operational capabilities and scientific direction. Specifically, he leveraged expertise in molecular engineering toward the generation of new high value assets. Prior to Cue Biopharma Dr. Seidel was a Research Assistant Professor of Biochemistry and Associate Director of the Macromolecular Therapeutic Development Facility (MTDF) at the Albert Einstein College of Medicine. The function of the MTDF was to leverage high throughput technologies for the development, analysis and production of protein-based therapeutics. Additionally, through the MTDF, Dr. Seidel was the Associate Director of Eukaryotic Protein Production at the Northeast BioDefense Center (NBC). He has also served as a consultant to the industry in biologics and protein production. Dr. Seidel holds a B.S. and Ph.D. in Biochemistry from the University of Georgia. He did his post-doctoral work at the New York Structural Biology Center.

« Go Back